Collins v. Milliman Inc

District Court, W.D. Washington·Decided June 8, 2023·No. 2:22-cv-00061·Unknown

Opinion

HONORABLE RICHARD A. JONES

UNITED STATES DISTRICT COURT AT SEATTLE STEVE COLLINS, an individual,

Plaintiff, Case No. 2:22-cv-0061-RAJ v. ORDER ON THE PARTIES’ MOTIONS IN LIMINE MILLIMAN, INC., Defendant. This matter comes before the Court on the parties’ motions in limine. Dkt. ## 56, 58. As discussed below, the Court GRANTS in part and DENIES in part the parties’ motions. The Court also TAKES UNDER ADVISEMENT certain motions until trial so that the parties provide further information on the admissibility of specific evidence. Parties may file motions in limine before or during trial “to exclude anticipated prejudicial evidence before the evidence is actually offered.” Luce v. United States, 469 U.S. 38, 40 n. 2 (1984). To decide on motions in limine, the Court is generally guided by Federal Rules of Civil Procedure 401 and 403. Specifically, the Court considers whether the evidence “has any tendency to make a fact more or less probable than it would be without the evidence,” and whether “the fact is of consequence in determining the action.” Fed. R. Civ. P. 401. However, the Court may exclude relevant evidence if “its probative value is substantially outweighed by a danger of one or more of the following: unfair prejudice, confusing the issues, misleading the jury, undue delay, wasting time, or needlessly presenting cumulative evidence.” Fed. R. Civ. P. 403. In October 2021, Plaintiff Steve Collins applied for life insurance with two insurance companies, Americo and Mutual of Omaha. Dkt. # 31-5; Dkt. # 31-6. As part of the application process, both insurers requested a consumer report from Defendant Milliman, Inc. (“Milliman”) on Collins’s medical and prescription history. See Dkt. # 32. Collins claims that the insurers denied the applications because the medical history incorrectly indicated that Mr. Collins had heart disease and dementia/amnesia. Dkt. # 31- 3 at 13, 39; Dkt. # 31-20 at 3. After Collins’s applications were declined, he requested and received a copy of his Milliman consumer reports. Dkt. # 32-1. Around October 20, 2021, Collins called Milliman to dispute the inaccurate medical records and open an investigation. Dkt. # 31-2 at 29. Collins claims that Milliman instructed him to contact doctors to confirm that he was never a patient. Id. Collins claims that the doctors refused to verify this information and advised he seek representation. Id. at 15. On January 24, 2022, Mr. Collins filed his lawsuit against Milliman alleging that Milliman violated the Fair Credit Reporting Act (“FCRA”) by (1) failing to maintain reasonable procedures to ensure the maximum possible accuracy of its consumer reports by allegedly including inaccurate items on his consumer report and (2) by failing to reinvestigate his consumer dispute. Dkt. # 1. In December 2022, the parties filed motions for summary judgment and motions to seal certain exhibits. Dkt. ## 28, 29, 33 34. In February 2023, the Court granted the motions to seal and denied the motions for summary judgment. Dkt. # 61. Soon thereafter, the parties filed motions in limine. Dkt. ## 56, 58. The parties agree to, and the Court accepts, certain motions in limine Nos. A-H. These motions cover several issues regarding expert reports, witnesses in the court room, certain evidence and exhibits to be prohibited, and defense counsel resources. Dkt. # 56 at 1-2. B. PLAINTIFF’S MOTIONS IN LIMINE The disputed issues raised by Plaintiff are resolved as discussed below: 1. MIL # 1: Discussion of non-party Optum’s procedures Plaintiff seeks to exclude evidence regarding the policies and procedures of Optum, one of the third-party providers of medical and prescription information to Milliman. Dkt # 56 at 4. Plaintiff argues that this information is relevant because Milliman has the ultimate responsibility for assuming accuracy of the information and conducting a reasonable investigation. Id. Plaintiff’s motion is DENIED. Evidence regarding what Milliman knew of Optum’s data handling and accuracy is relevant to whether Millman’s own policies and procedures were reasonable. Plaintiff also insists that evidence regarding Optum should be excluded because evidence of those procedures were not produced in discovery. However, Milliman lists Optum as a potential source of discoverable information on its supplement initial disclosures. Dkt. # 58-2. To the extent that Plaintiff seeks to prevent certain undisclosed documents from being offered at trial, the Court will not rule in a vacuum. Plaintiff is free to object to the admission of any such documents at trial. 2. MIL # 2: Excluding evidence of Plaintiff’s medical ailments Plaintiff seeks to preclude evidence and testimony about whether he may have dementia, amnesia, or other heart ailments. Dkt. # 58 at 8. According to Plaintiff, there is no admissible evidence to support those conclusions. Id. In response, Milliman argues Plaintiff’s medical history is both relevant and essential to the dispute. The Court agrees that Plaintiff’s medical history and whether it was accurately reported by Milliman is squarely relevant to the claims in this case. To the extent that Plaintiff seeks to prevent certain documents from being offered at trial, the Court will not rule in a vacuum. Plaintiff is free to object to the admission of any such documents at trial. The Court DENIES the motion. 3. MIL # 3: Excluding evidence regarding Plaintiff’s residence Plaintiff seeks to prevent Milliman from offering evidence that Collins may have lived in Nevada, or visited a health provider there. Dkt. # 58 at 10. Again, Plaintiff’s medical history is both relevant and essential to the dispute. This includes where and when Plaintiff may have visited doctors to the extent that Plaintiff is challenging the inaccurate reporting of his health history. For these reasons, the Court DENIES the motion. 4. MIL # 4: Excluding evidence that the FCRA requires a “written dispute” Plaintiff seeks to preclude evidence and testimony that the FCRA requires written notice to reinvestigate a consumer complaint. Dkt. # 58 at 10. It is well settled that the court instructs the jury on the law. United States v. Weitzenhoff, 35 F.3d 1275, 1287 (9th Cir. 1993). Nonetheless, nothing prevents Milliman from providing evidence of how, in its experience, their representatives typically handle consumer complaints. That said, Milliman cannot provide testimony on whether “written” notice is needed to comply with the FCRA. To the extent that this motion seeks to prevent Milliman from stating a legal conclusion regarding the FCRA, the motion is GRANTED. 5. MIL # 5: Excluding communications between counsel since the filing of the complaint Plaintiff primarily seeks to preclude a March 2022 “written” communication between the parties regarding additional disputed medical records. Plaintiff argues that his legal claims in this dispute are limited to the Defendant’s procedures and failure to reinvestigate based upon notice received in October 2021. Dkt. # 58 at 12. While nothing precludes Milliman from presenting evidence that it requires written confirmation as part of its reinvestigation process, the Court agrees that the March 2022 communication is irrelevant to Milliman’s reinvestigation process as it relates to notice received in March 2021. The agency must complete the investigation within 30 days. 15 U.S.C. § 1681i(a)(2). Attempting to use post-litigation conduct to show the reasonableness of its procedures has a hig

Free access — add to your briefcase to read the full text and ask questions with AI

Collins v. Milliman Inc, (W.D. Wash. 2023).

Collins v. Milliman Inc (Collins v. Milliman Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related